JP2013540766A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013540766A5 JP2013540766A5 JP2013532316A JP2013532316A JP2013540766A5 JP 2013540766 A5 JP2013540766 A5 JP 2013540766A5 JP 2013532316 A JP2013532316 A JP 2013532316A JP 2013532316 A JP2013532316 A JP 2013532316A JP 2013540766 A5 JP2013540766 A5 JP 2013540766A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- copper oxide
- inhibitor
- skin
- oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 26
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims 22
- 229960004643 cupric oxide Drugs 0.000 claims 20
- 239000005751 Copper oxide Substances 0.000 claims 18
- 229910000431 copper oxide Inorganic materials 0.000 claims 18
- 239000003112 inhibitor Substances 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 4
- -1 prostanoic acid prostaglandin Chemical class 0.000 claims 4
- 150000003431 steroids Chemical class 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 2
- 101800004538 Bradykinin Proteins 0.000 claims 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 2
- 108010036949 Cyclosporine Proteins 0.000 claims 2
- 229940122069 Glycosidase inhibitor Drugs 0.000 claims 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims 2
- 102100035792 Kininogen-1 Human genes 0.000 claims 2
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 claims 2
- 229940122142 Lipoxygenase inhibitor Drugs 0.000 claims 2
- 229940118169 Prostaglandin receptor agonist Drugs 0.000 claims 2
- 229940122144 Prostaglandin receptor antagonist Drugs 0.000 claims 2
- 102000003923 Protein Kinase C Human genes 0.000 claims 2
- 108090000315 Protein Kinase C Proteins 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000002280 anti-androgenic effect Effects 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 2
- 239000000051 antiandrogen Substances 0.000 claims 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims 2
- 229960001265 ciclosporin Drugs 0.000 claims 2
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 229940112669 cuprous oxide Drugs 0.000 claims 2
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical group [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 claims 2
- 229930182912 cyclosporin Natural products 0.000 claims 2
- 230000007547 defect Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229960005309 estradiol Drugs 0.000 claims 2
- 229930182833 estradiol Natural products 0.000 claims 2
- 229940011871 estrogen Drugs 0.000 claims 2
- 239000000262 estrogen Substances 0.000 claims 2
- 239000006260 foam Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000003316 glycosidase inhibitor Substances 0.000 claims 2
- 230000007803 itching Effects 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 239000002089 prostaglandin antagonist Substances 0.000 claims 2
- 239000002522 prostaglandin receptor stimulating agent Substances 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 229930002330 retinoic acid Natural products 0.000 claims 2
- 150000004492 retinoid derivatives Chemical class 0.000 claims 2
- 230000009759 skin aging Effects 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 229960001727 tretinoin Drugs 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38929010P | 2010-10-04 | 2010-10-04 | |
| US61/389,290 | 2010-10-04 | ||
| PCT/IL2011/000769 WO2012046229A2 (en) | 2010-10-04 | 2011-10-03 | Cosmetic skin care compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013540766A JP2013540766A (ja) | 2013-11-07 |
| JP2013540766A5 true JP2013540766A5 (OSRAM) | 2014-11-20 |
Family
ID=44936331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013532316A Pending JP2013540766A (ja) | 2010-10-04 | 2011-10-03 | 化粧用スキンケア組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140065196A1 (OSRAM) |
| EP (1) | EP2624806B1 (OSRAM) |
| JP (1) | JP2013540766A (OSRAM) |
| KR (1) | KR20140008299A (OSRAM) |
| CN (1) | CN103442678A (OSRAM) |
| BR (1) | BR112013008173A2 (OSRAM) |
| WO (1) | WO2012046229A2 (OSRAM) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005303369B2 (en) | 2004-11-09 | 2011-08-04 | Cupron Inc. | Methods and materials for skin care |
| KR101474998B1 (ko) | 2012-11-28 | 2014-12-19 | 롯데푸드 주식회사 | 피부 주름 생성 억제 및 주름 개선 활성을 갖는 백차 추출물을 함유하는 조성물 |
| CN104042502B (zh) * | 2014-06-10 | 2016-04-27 | 刘佰岭 | 一种深层渗透吸收并促进新陈代谢延缓衰老的护肤组合物 |
| CN107207771B (zh) | 2015-02-08 | 2019-12-06 | 阿尔贾曼技术有限公司 | 包含金属氧化物的协同组合的抗微生物材料 |
| US11224227B2 (en) | 2015-02-08 | 2022-01-18 | Argaman Technologies Ltd. | Antimicrobial material comprising synergistic combinations of metal oxides |
| TWI754608B (zh) * | 2015-02-08 | 2022-02-11 | 以色列商阿爾賈曼技術有限公司 | 包含金屬氧化物之協同組合的皮膚再生材料 |
| US10076552B2 (en) | 2016-08-09 | 2018-09-18 | DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. | Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof |
| KR102499651B1 (ko) * | 2016-11-10 | 2023-02-13 | 에이에스씨 리제니티 리미티드 | 에리트로포이에틴-유래 분자를 함유하는 국소 적용을 위한 미용 제형 |
| US11337908B2 (en) | 2016-12-21 | 2022-05-24 | Conopco, Inc. | Personal care compositions with cystine |
| CA3046037A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
| US10919925B2 (en) * | 2017-05-26 | 2021-02-16 | Tess Griffiths | Liquid composition for reconstituting pressed powder cosmetics |
| SI25540A (sl) * | 2019-01-14 | 2019-05-31 | Tompa Majcen Dominika | Formulacije s spojinami aktivnega kisika in pripomočki za njihovo aplikacijo |
| AU2019100909A6 (en) * | 2019-06-04 | 2019-10-17 | Avgol Ltd. | Dead sea mineral based implementation in high performance nonwoven fabrics |
| CN111481528A (zh) * | 2020-03-23 | 2020-08-04 | 北京和正堂生物科技有限公司 | 基于穴位经皮给药的药物载体与药物组合物及其制备方法与应用 |
| CN115024997B (zh) * | 2022-05-24 | 2023-11-17 | 彭氏(惠州)实业发展有限公司 | 具有抗皮肤衰老功效的化妆品组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692482A1 (fr) * | 1992-06-22 | 1993-12-24 | David Zaboud Louisa | Produit pour cheveux à base de produits naturels servant à raidir, teinter et embellir. |
| US5631013A (en) * | 1995-08-07 | 1997-05-20 | Church & Dwight Co., Inc. | Cosmetic deodorant products containing encapsulated co-micronized bicarbonate ingredient |
| FR2789682B1 (fr) | 1999-02-12 | 2001-05-04 | Oreal | Nouveaux derives silicies de benzimidazole-benzazoles n-substitues ou de benzofuranyl-benzazoles filtres, compositions cosmetiques photoprotectrices les contenant et utilisations |
| KR101528918B1 (ko) * | 2004-11-07 | 2015-06-15 | 쿠프론 인코포레이티드 | 상처, 화상 및 다른 피부 질환을 치료하기 위한 구리 함유물질 |
| IL165118A0 (en) * | 2004-11-09 | 2005-12-18 | Cupron Corp | Methods and materials for skin care |
| AU2005303369B2 (en) * | 2004-11-09 | 2011-08-04 | Cupron Inc. | Methods and materials for skin care |
| RU2007134270A (ru) * | 2005-03-21 | 2009-03-20 | Зе Капрон Корпорейшн (Us) | Противомикробная и противовирусная полимерная маточная смесь, способы производства полимерных материалов из нее и продукты, полученные из нее |
| MX2008004981A (es) * | 2005-10-16 | 2008-10-17 | Lycored Ltd | Composiciones para el tratamiento de enfermedades de los ojos. |
| JP5038331B2 (ja) * | 2006-02-03 | 2012-10-03 | ジェイアール ケム エルエルシー | 銅と亜鉛の組成物を用いた老化防止治療 |
| FR2901140B1 (fr) * | 2006-05-22 | 2008-07-18 | Daniel Lichtenstein | Produit fluide de couplage pour echographie |
| US20110229536A1 (en) | 2008-05-12 | 2011-09-22 | Tagra Biotechnologies Ltd. | Compositions for topical application comprising microencapsulated colorants |
| IL201884A0 (en) * | 2009-11-02 | 2010-06-30 | Cupron Corp | Hair care compositions and materials |
-
2011
- 2011-10-03 JP JP2013532316A patent/JP2013540766A/ja active Pending
- 2011-10-03 EP EP11781877.3A patent/EP2624806B1/en active Active
- 2011-10-03 CN CN201180048047XA patent/CN103442678A/zh active Pending
- 2011-10-03 BR BR112013008173A patent/BR112013008173A2/pt not_active IP Right Cessation
- 2011-10-03 US US13/877,449 patent/US20140065196A1/en not_active Abandoned
- 2011-10-03 KR KR1020137008516A patent/KR20140008299A/ko not_active Withdrawn
- 2011-10-03 WO PCT/IL2011/000769 patent/WO2012046229A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013540766A5 (OSRAM) | ||
| US8834940B2 (en) | Compositions and method for hair loss prevention | |
| JP2014511393A5 (OSRAM) | ||
| JP2005526822A5 (OSRAM) | ||
| JP6132360B2 (ja) | ジインドリルメタン及びレチノイドを含む皮膚症状を治療するための組成物 | |
| CN101785751B (zh) | 用于一次性卫生用品的缓释清凉剂和制备方法及应用 | |
| JP2012236834A5 (OSRAM) | ||
| RU2014142066A (ru) | Состав с длительным высвобождением для снижения частоты мочеиспускания и способ его применения | |
| MY173582A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| GB2484812A (en) | Composition for reducing hair loss/improving hair condition | |
| US20120064174A1 (en) | Method for stimulating hair growth | |
| JP2017528505A5 (OSRAM) | ||
| MX339685B (es) | Formulaciones de (trimetoxifenilamino) pirimidinilo nuevas. | |
| WO2009111688A3 (en) | All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof | |
| WO2012075093A3 (en) | Topical formulations for administration of omega-3 fatty acids | |
| ES2390504T3 (es) | Combinación de principios activos de un retinoide y una combinación de hormonas con efecto anticonceptivo como fármaco para el tratamiento de enfermedades cutáneas | |
| JP2015081244A (ja) | ニキビ治療用医薬組成物 | |
| US20130316017A1 (en) | Oral Composition for the Treatment of Acne | |
| JP2015110557A (ja) | ロキソプロフェンを配合する外用剤組成物 | |
| JP6253495B2 (ja) | ロキソプロフェンを含有する外用剤組成物 | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone | |
| KR101548254B1 (ko) | 유황, 명반 및 식초를 유효성분으로 포함하는 피부 질환 치료용 조성물 | |
| Asz-Sigall et al. | Seborrheic Dermatitis | |
| PE20151418A1 (es) | Formulacion farmaceutica de n-[5-[2-(3,5-dimetoxifenil)etil]-2h-pirazol-3-il]-4-[(3r,5s)-3,5-dimetilpiperazin-1-il]benzamida | |
| WO2015027669A3 (zh) | 苯基取代化合物及其药物组合物和应用 |